VKTX Jun 2024 36.000 call
- Insider Monkey
Here’s Why Viking Therapeutics (VKTX) Stock Skyrocketed in Q1
Wasatch Global Investors, an asset management company, released its “Wasatch Micro Cap Growth—U.S. Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. During the first quarter, the micro-cap equities performed well. The strategy had a double-digit gain in the quarter, outperforming the Russell Microcap Growth Index benchmark, which rose 6.60%. […]
- Zacks
Viking Therapeutics, Inc. (VKTX) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $52.10, denoting a -0.69% change from the preceding trading day.
- Zacks
Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?
According to the average brokerage recommendation (ABR), one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
